CSIMarket
 

Iovance Biotherapeutics Inc   (IOVA)
Other Ticker:  
 

Iovance Biotherapeutics Inc 's

Competitiveness


 

IOVA Sales vs. its Competitors Q4 2023







Revenue Growth Comparisons




Net Income Comparison




<<  IOVA Stock Performance Comparisons



*Market share is calculated based on total revenue.

  News about Iovance Biotherapeutics Inc Contracts

Iovance's AMTAGVI Wins FDA Approval, Unleashing the Power of T Cell Therapy Against Advanced Melanoma

Iovance's AMTAGVI (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced MelanomaIn a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Iovance Biotherapeutics' AMTAGVI (lifileucel), making it the first FDA-approved T cell therapy for a solid tumor cancer. Specifically designed as a treatment option for advanced melanoma patients who have undergone anti-PD-1 and targeted therapy, this approval marks a significant leap forward in the fight against this devastating disease.Melanoma, the most severe type of skin cancer, affects thousands of individuals each year. Despite advancements in other forms of cancer treatment, patients with advanced me...

Revolutionizing the Fight Against Non-Small Cell Lung Cancer: Iovance Biotherapeutics Unveils Clinical Trial Updates for Groundbreaking LN-145

The arena of cancer research and treatment is continually evolving with the tireless efforts and innovation of biotechnology firms globally. One such entity leading the charge is Iovance Biotherapeutics, Inc. (NASDAQ: IOVA). The biotechnology company, rooted firmly in the development and deployment of pioneering polyclonal tumor-infiltrating lymphocyte (TIL) therapies for cancer patients, has lately revealed an update regarding their clinical trials for LN-145 TIL therapy.Located in San Carlos, California, Iovance Biotherapeutics has been diligently researching and conducting clinical trials on LN-145, a promising TIL therapy specifically targeted at non-small cell lung cancer (NSCLC) patients. The company r...





Who are Iovance Biotherapeutics Inc 's Competitors?





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com